Asthma Flashcards

1
Q

Define: Asthma

A

chronic inflammatory disorders of the airways which contributes to airway hyperresponsiveness, airflow limitation, respiratory symptoms, and disease chronicity. acute bronchoconstriction, airway edema, mucus plug formation, and airway wall remodeling leading to bronchial obstruction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is asthma severity classified?

A

consider impairment (present), including frequency and intensity of symptoms and quality of life and risk (future), including exacerbations, loss of pulmonary function, risk of adverse drug reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the use of severity classification of asthma?

A

initiating controller (long-term control) therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What drugs are considered quick relief (“relievers”)?

A

-short-acting beta2-agonists (SABA)
-short-acting anticholinergics (SAMA)
-systemic corticosteroids (OCS)
-long-acting beta2-agonists/inhaled corticosteroids combo (LABA/ICS combo)
-short-acting beta2-agonist/inhaled corticosteroid combo (SABA/ICS combo)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What drugs are considered long-term controllers?

A

-inhaled corticosteroids (ICS)
-mast cell stabilizers
-long-acting beta2-agonists (LABA)
-methylxanthines
-leukotriene modifiers (LM)
-long-acting beta2-agonists (LABA)/ inhaled corticosteroid (ICS)
-monoclonal antibodies
-long-acting anticholinergics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What drugs are short-acting beta2-agonists?

A

-albuterol (Proventil HFA, Ventolin HFA, ProAir Respiclick)
-levobuterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the indications for SABAs use?

A

-quick relief of acute symptoms
-preventive prescription prior to exercise-induced bronchospasm (EIB)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

MOA: Short-acting beta2-agonists (SABAs)

A

-activation of adenylate cyclase and increase cyclic AMP
-smooth muscle relaxation -> bronchodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Side Effects: SABAs

A

-tremor
-tachycardia, palpitations
-hypokalemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the difference between levalbuterol vs albuterol?

A

it is suggested that levalbuterol has possible more rapid onset and fewer side effects than albuterol (lacks evidence) but there is no clinically significant difference and levalbuterol can be more expensive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What drugs is most effective for relieving acute bronchospasms?

A

SABAs (albuterol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the concern of SABA daily use?

A

daily use is associated with beta-receptor down regulation which can cause hyperresponsiveness to allergens and increased inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How may a patient use their SABA that may indicate the need for long-term control medication ?

A

if the patient use > 1 canister (1 inhaler) a month or >2 times a week

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are OTC SABAs and why are they NOT recommended?

A

they are non-selective adrenergic agonists (alpha and beta) with increased side effects such as increased HR, palpitations, HTN, angina, arrhythmias, seizures, hyperglycemia, temor, anxiety/nervousness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What drugs are short-acting anticholinergics (SAMAs)?

A

ipratropium bromide (Atrovent HFA, nebulization soln)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the indication for short-acting anticholinergics (SAMAs)?

A

relief of acute bronchospasms
no effect of exercise-induced bronchospasms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

MOA: SAMAs

A

bronchodilation via inhibition of muscarinic cholinergic receptors reduction of glandular mucus secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Side Effects: SAMAs

A

anticholinergic side effects, but mostly dry mouth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Can SAMAs be used alone for acute bronchospasms?

A

no, may be given with albuterol

20
Q

When may a SAMA be uniquely used for treatment?

A

it is used in the emergency department (ED) with albuterol for acute exacerbations because it may reduce the likelihood of admission and reduce the length of stay of a patient who may need to be admitted. BUT it is NOT recommended in hospitalized patients!

21
Q

What is the indication for SYSTEMIC corticosteroids?

A

moderate to severe exacerbations to prevent the progression of the exacerbation, reverse inflammation, speed recovery, reduce rate of relapse

22
Q

What is the typically dosing of systemic corticosteroids for an asthma exacerbation?

A

-adults: prednisone 40mg-60mg po daily (or divided BID) x 3-10 days
-children: prednisolone 1-2mg/kg/day (max=60mg) po x 3-10 days

23
Q

Side Effects: Systemic Corticosteroids

A

-abnormalities in glucose metabolism
-increased appetite
-fluid retention
-weight gain
-mood alteration
-hypertension
-peptic ulceration

24
Q

What is “SMART” therapy?

A

“single maintenance and reliever therapy” includes the combo product long-acting beta2-agonist/inhaled corticosteroid (LABA/ICS)

25
Q

What LABA/ICS combo may be given for quick-relief of acute asthma symptoms?

A

formoterol containing products only (Symbicort and Dulera)

26
Q

What is “AIR” therapy?

A

“anti-inflammatory reliever which includes a SABA/ICS combo

27
Q

What products are short-acting beta2-agonist(SABA)/inhaled corticosteroid (ICS)?

A

Airspura (albuterol/budesonide)

28
Q

What products are inhaled corticosteroids (ICS)?

A

-beclomethasone
-budesonide
-ciclesonide
-fluticasone propionate
-fluticasone furoate
-mometasone furoate

29
Q

What is the indication of inhaled corticosteroids (ICS)?

A

-long-term prevention of symptoms in mild-persistent, moderate, and severe asthma
-suppression, control, and reversal of inflammation
-reduce the need for systemic corticosteroids

30
Q

MOA: inhaled corticosteroids

A

-reduce synthesis and release of pro-inflammatory cytokines
-reduce inflammatory cell activation, recruitment, and infiltration
-reduce vascular permeability
-may increase number of receptors and may improve receptor responsiveness to adrenergic stimulation (synergistic effect)

31
Q

Side Effects: inhaled corticosteroids

A

-cough, dysphonia
-oral thrush (candidiasis)
-possible systemic effects seen at high doses (adrenal suppression/growth suppression, osteoporosis, skin thinning/easy bruising, weight gain/fluid retention)

32
Q

What are tips for patients to reduce adverse effects of ICS?

A

-administer with spacer if possible
-rinse mouth thoroughly after inhalation
-use lowest effective dose
-monitor growth
-consider osteoporosis prophylaxis in postmenopausal women

33
Q

What is ICS place in treatment?

A

first-line treatment for long-term control regardless of age

34
Q

What products are mast cell stbilizers?

A

cromolyn sodium

35
Q

What is the indication of mast cell stabilizers?

A

-long-term prevention of symptoms
-preventative treatment prior to exposure to exercise or known allergen

36
Q

What products are long-acting beta-agonists (LABAs)?

A

-salmeterol
-formoterol
-vilanterol
-albuterol SR tabs

37
Q

What are the indications of long-acting beta-agonists (LABAs)?

A

-long-term prevention of symptoms, especially nocturnal symptoms IN ADDITION TO anti-inflammatory agents
-prevention of exercise induced bronchospasms (EIB)
-relief of acute bronchospasms (off labeled use and FORMOTEROL containing products)

38
Q

What age is Salmeterol (LABA) approved in?

A

4 years+

39
Q

What age is Formoterol (LABA) approved in?

A

5 years+ (no longer marketed)

40
Q

What products are Methyxanthines?

A

theophylline

41
Q

What is the indication of methylxanthines?

A

long-term control and prevention of symptoms, especially nocturnal symptoms

42
Q

Why are Methylxanthines not generally recommended to use for treatment of asthma?

A

narrow therapeutic window so serum concentration monitoring is required so it is poorly tolerated and numerous drug interactions

43
Q

What products are leukotriene modifiers (LM)?

A

-zafirlukast
-zileuton
-montelukast

44
Q

What is the indication of leukotriene modifiers?

A

long-term control and prevention of symptoms in persistent asthma

45
Q

When may leukotriene modifiers (LM) be helpful for treatment?

A

children or patients with poor inhaler technique

46
Q
A